[{"Assets_0_Q3_USD":489549000.0,"CommonStockSharesOutstanding_0_Q3_shares":15393309.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-19242000.0,"NetIncomeLoss_1_Q3_USD":-8512000.0,"NetIncomeLoss_3_Q3_USD":-21336000.0,"StockholdersEquity_0_Q3_USD":482907000.0,"Ticker":"MDGL","CIK":"1157601","name":"MADRIGAL PHARMACEUTICALS, INC.","OfficialName":"Madrigal Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2018.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1322434501.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20181106"}]